Rebalix
Logo LGIMLGIM · sheet of 10 September 2026
ETF sheet · official issuer and register data

L&G MSCI Europe Select UCITS ETF

RIEU · IE00BKLTRN76 · class EUR Acc. · EUR · domicile Ireland
Equity · EuropeSFDR art. 8
Index tracked: MSCI Global Select 500 – Europe Subset
TER
0.10%+ trans. 0.54%
Fund size
444 m EUR
Tracking difference
+0.05%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical (sampled)
Income
Accumulating
Launch 17 Sept 2019 · costs from the KID as of 2 Sept 2026 · 0 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The investment objective of the Fund is to provide reduced greenhouse gas emissions exposure to equity markets in Europe. The Fund is passively managed and aims to track the performance of the MSCI Global Select 500 Index – Europe Subset (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to equity securities from European countries that meet defined size and liquidity criteria, in accordance with its methodology. The Fund seeks to achieve its investment objective using an optimisation/representative…

Performance since series start (in euro) — base 100

29 Aug 201931 Jul 2026 · dividends reinvested where declared by the issuer
202020212022202320242025202619777197
High 197 (31 Jul 2026) · low 77 (18 Mar 2020) · last 197. Past performance is not indicative of future results.

Returns in euro

1 year+17.0%
3 years+41.5%
5 years+49.1%
10 yearsseries too young
Since series start+96.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.80%12.23%13.99%
Max drawdown−10.11%−15.99%−22.58%
Sharpe1.160.840.43
Sortino1.751.180.60
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · RIEU · IE00BKLTRN761
RebalixRIEU · IE00BKLTRN76 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+15.76%+15.61%+0.15%
2024+9.59%+9.72%−0.12%
2023+16.57%+16.44%+0.13%
2022−13.30%−13.42%+0.12%
2021+24.97%+24.88%+0.09%

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 22.5%
Top holdingsWeight
ASML4.7%
HSBC2.6%
Roche2.4%
Novartis2.3%
Nestle2.0%
AstraZeneca1.9%
Siemens1.9%
Santander1.6%
Schneider Electric1.6%
SAP1.5%
Countries (% of fund)
Regno Unito24.3%Svizzera15.2%Francia14.1%Germania13.9%Paesi Bassi8.6%
Sectors (% of fund)
Finanziari22.8%Industriali20.6%Assistenza sanitaria12.5%Beni di consumo primari8.8%Informatica8.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
RIEU · Borsa Italiana (ETFplus)
DELF · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 12 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/7610a749-294a-447e-b9ac-230d67c
Factsheet · fundcentres.landg.com/srp/documents-id/8f10463a-9520-45ba-9fd2-ad8467a
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE00BKLTRN76
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · RIEU · IE00BKLTRN762